ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/11/07 | 2,535 | 2,578 | 2,511 | 2,513 | -6 | -0.2% | 1,326,400 |
2019/11/06 | 2,530 | 2,538 | 2,480 | 2,519 | -12 | -0.5% | 936,300 |
2019/11/05 | 2,596 | 2,600 | 2,528 | 2,531 | -39 | -1.5% | 1,733,600 |
2019/11/01 | 2,545 | 2,577 | 2,527 | 2,570 | +25 | +1% | 1,297,400 |
2019/10/31 | 2,520 | 2,556 | 2,500 | 2,545 | +45 | +1.8% | 1,582,900 |
2019/10/30 | 2,489 | 2,568 | 2,469 | 2,500 | +28 | +1.1% | 2,734,500 |
2019/10/29 | 2,448 | 2,481 | 2,422 | 2,472 | +18 | +0.7% | 1,172,700 |
2019/10/28 | 2,427 | 2,493 | 2,415 | 2,454 | +51 | +2.1% | 1,788,300 |
2019/10/25 | 2,350 | 2,403 | 2,331 | 2,403 | +40 | +1.7% | 1,258,100 |
2019/10/24 | 2,409 | 2,427 | 2,361 | 2,363 | -37 | -1.5% | 1,454,900 |
2019/10/23 | 2,370 | 2,431 | 2,365 | 2,400 | +50 | +2.1% | 1,589,600 |
2019/10/21 | 2,301 | 2,365 | 2,276 | 2,350 | +43 | +1.9% | 1,323,600 |
2019/10/18 | 2,245 | 2,322 | 2,245 | 2,307 | +72 | +3.2% | 1,301,700 |
2019/10/17 | 2,195 | 2,260 | 2,191 | 2,235 | +39 | +1.8% | 1,112,700 |
2019/10/16 | 2,213 | 2,222 | 2,167 | 2,196 | +5 | +0.2% | 1,051,600 |
2019/10/15 | 2,165 | 2,226 | 2,139 | 2,191 | +41 | +1.9% | 1,285,500 |
2019/10/11 | 2,235 | 2,249 | 2,138 | 2,150 | -78 | -3.5% | 2,207,500 |
2019/10/10 | 2,343 | 2,353 | 2,223 | 2,228 | -125 | -5.3% | 2,249,900 |
2019/10/09 | 2,382 | 2,424 | 2,335 | 2,353 | -64 | -2.6% | 1,827,900 |
2019/10/08 | 2,375 | 2,431 | 2,332 | 2,417 | +34 | +1.4% | 1,544,300 |
2019/10/07 | 2,459 | 2,461 | 2,382 | 2,383 | -55 | -2.3% | 1,298,000 |
2019/10/04 | 2,440 | 2,454 | 2,390 | 2,438 | +22 | +0.9% | 1,197,100 |
2019/10/03 | 2,435 | 2,455 | 2,408 | 2,416 | -54 | -2.2% | 1,073,700 |
2019/10/02 | 2,427 | 2,482 | 2,408 | 2,470 | +39 | +1.6% | 1,377,200 |
2019/10/01 | 2,451 | 2,591 | 2,389 | 2,431 | +8 | +0.3% | 4,546,500 |
2019/09/30 | 2,484 | 2,506 | 2,347 | 2,423 | -36 | -1.5% | 2,448,200 |
2019/09/27 | 2,494 | 2,535 | 2,432 | 2,459 | -36 | -1.4% | 1,806,400 |
2019/09/26 | 2,499 | 2,525 | 2,451 | 2,495 | +21 | +0.8% | 1,638,500 |
2019/09/25 | 2,489 | 2,523 | 2,410 | 2,474 | -15 | -0.6% | 2,244,600 |
2019/09/24 | 2,341 | 2,529 | 2,341 | 2,489 | +154 | +6.6% | 3,986,300 |
2019/09/20 | 2,260 | 2,390 | 2,260 | 2,335 | +85 | +3.8% | 2,685,200 |
2019/09/19 | 2,233 | 2,312 | 2,220 | 2,250 | +30 | +1.4% | 1,565,300 |
2019/09/18 | 2,210 | 2,253 | 2,181 | 2,220 | +7 | +0.3% | 1,479,500 |
2019/09/17 | 2,219 | 2,240 | 2,088 | 2,213 | -13 | -0.6% | 1,970,500 |
2019/09/13 | 2,268 | 2,282 | 2,207 | 2,226 | -28 | -1.2% | 1,950,000 |
2019/09/12 | 2,363 | 2,386 | 2,252 | 2,254 | -87 | -3.7% | 2,619,200 |
2019/09/11 | 2,300 | 2,359 | 2,270 | 2,341 | +39 | +1.7% | 1,943,200 |
2019/09/10 | 2,286 | 2,337 | 2,281 | 2,302 | +16 | +0.7% | 1,409,800 |
2019/09/09 | 2,312 | 2,328 | 2,280 | 2,286 | -49 | -2.1% | 1,579,300 |
2019/09/06 | 2,326 | 2,368 | 2,307 | 2,335 | +28 | +1.2% | 1,700,400 |
2019/09/05 | 2,288 | 2,315 | 2,255 | 2,307 | +40 | +1.8% | 1,682,900 |
2019/09/04 | 2,307 | 2,329 | 2,263 | 2,267 | -38 | -1.6% | 1,520,000 |
2019/09/03 | 2,317 | 2,349 | 2,288 | 2,305 | -12 | -0.5% | 1,363,000 |
2019/09/02 | 2,270 | 2,335 | 2,242 | 2,317 | +35 | +1.5% | 1,475,300 |
2019/08/30 | 2,247 | 2,308 | 2,179 | 2,282 | +56 | +2.5% | 2,769,100 |
2019/08/29 | 2,282 | 2,330 | 2,192 | 2,226 | -48 | -2.1% | 3,107,700 |
2019/08/28 | 2,303 | 2,345 | 2,265 | 2,274 | -64 | -2.7% | 2,913,100 |
2019/08/27 | 2,450 | 2,452 | 2,333 | 2,338 | -76 | -3.1% | 2,218,300 |
2019/08/26 | 2,465 | 2,488 | 2,409 | 2,414 | -98 | -3.9% | 2,305,800 |
2019/08/23 | 2,475 | 2,538 | 2,448 | 2,512 | +37 | +1.5% | 1,997,700 |
1201~
1250
件表示中 / 4943件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 125,100円 | +197.7% | - | 0.00% | 51.12倍 | 1.63倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
持田薬 | 346,000円 | +3.0% | +27.5% | 2.31% | 21.90倍 | 0.95倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ゼリア新薬 | 233,800円 | +9.6% | +17.5% | 1.97% | 13.21倍 | 1.30倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 393,500円 | +11.1% | +20.6% | 3.05% | 23.05倍 | 0.92倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
杏林製薬 | 153,100円 | +3.2% | +4.5% | 3.40% | 17.59倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム